We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01616927
First Posted: June 12, 2012
Last Update Posted: May 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Leiden University Medical Center
Erasmus Medical Center
Radboud University
Information provided by (Responsible Party):
dr. R.T. Gansevoort, University Medical Center Groningen